Skip to content

Clinical trials

Hypothermia trials with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypothermia Phase: Not applicable Clear all

228 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20031
20042
20051
20061
20074
20086
20095
201010
20114
20127
201314
201415
201514
201618
20179
201816
201917
202014
202116
202214
20239
202414
20258
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed136
Unknown status46
Terminated14
Withdrawn10
Recruiting10
Not yet recruiting5
Active, not recruiting4
Enrolling by invitation3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of Alabama at Birmingham9
Haukeland University Hospital5
The Cleveland Clinic5
Sunnybrook Health Sciences Centre4
Karolinska University Hospital3
NICHD Neonatal Research Network3
Seoul National University Hospital3
Stanford University3
University Hospital Schleswig-Holstein3
University of Manitoba3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypothermia228
Heart Arrest15
Premature Birth15
Body Temperature Changes9
Hyperthermia8
Hypoxia-Ischemia, Brain7
Out-of-Hospital Cardiac Arrest6
Hypoxia, Brain5
Ischemic Stroke5
Stroke5

Trials

Showing 1 to 25 of 228. Each trial links to its page on Pharma Observatory.

128 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.